Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
KLCA Korean Liver Cancer Association, NCC National Cancer Center
Gut and Liver (2019) Vol. 13, Iss. 3, pp. 227-299
Open Access | Times Cited: 349

Showing 1-25 of 349 citing articles:

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai‐Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 635
Targeted therapy for hepatocellular carcinoma
Ao Huang, Xin‐Rong Yang, Wen Yuan Chung, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 529
mRECIST for HCC: Performance and novel refinements
Josep M. Llovet, Riccardo Lencioni
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 288-306
Open Access | Times Cited: 463
Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
Ann‐Lii Cheng, Chiun Hsu, Stephen L. Chan, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 307-319
Open Access | Times Cited: 424
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Josep M. Llovet, Augusto Villanueva, Jorge A. Marrero, et al.
Hepatology (2020) Vol. 73, Iss. S1, pp. 158-191
Open Access | Times Cited: 319
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
Masatoshi Kudo, Kwang–Hyub Han, Sheng-Long Ye, et al.
Liver Cancer (2020) Vol. 9, Iss. 3, pp. 245-260
Open Access | Times Cited: 236
KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology (2019) Vol. 25, Iss. 2, pp. 93-159
Open Access | Times Cited: 190
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
L.-T. Chen, Erika Martinelli, Ann‐Lii Cheng, et al.
Annals of Oncology (2020) Vol. 31, Iss. 3, pp. 334-351
Open Access | Times Cited: 188
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 583-705
Open Access | Times Cited: 187
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
Tae Hyun Kim, Young Hwan Koh, Bo Hyun Kim, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 603-612
Open Access | Times Cited: 162
Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization
Hae Lim Lee, Jeong Won Jang, Sung Won Lee, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 154
Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study
Zhigang Fu, Xiaowei Li, Jiaming Zhong, et al.
Hepatology International (2021) Vol. 15, Iss. 3, pp. 663-675
Open Access | Times Cited: 139
Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis
Pankaj Gupta, Raghuraman Soundararajan, Ankur Patel, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 1, pp. 108-119
Closed Access | Times Cited: 115
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
Alessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 7, pp. e312-e322
Closed Access | Times Cited: 107
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology (2022) Vol. 23, Iss. 12, pp. 1126-1126
Open Access | Times Cited: 86
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Journal of Liver Cancer (2022) Vol. 23, Iss. 1, pp. 1-120
Open Access | Times Cited: 78
A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE
Masatoshi Kudo
Liver Cancer (2019) Vol. 8, Iss. 5, pp. 299-311
Open Access | Times Cited: 124
Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review
Jeongshim Lee, In‐Soo Shin, Won Sup Yoon, et al.
Radiotherapy and Oncology (2020) Vol. 145, pp. 63-70
Closed Access | Times Cited: 118
Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria
Seong Wook Shin, Keun Soo Ahn, Sang Woo Kim, et al.
Annals of Surgery (2020) Vol. 273, Iss. 4, pp. 656-666
Closed Access | Times Cited: 118
Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
Hyo Jung Cho, Jung Woo Eun, Geum Ok Baek, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 281-281
Open Access | Times Cited: 100
Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications
Hyungjin Rhee, Eun‐Suk Cho, Ji Hae Nahm, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 109-121
Closed Access | Times Cited: 97
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
Hwi Young Kim, Pietro Lampertico, Joon Yeul Nam, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 311-318
Closed Access | Times Cited: 89
Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
Abdul Rehman Khan, Xuyong Wei, Xiao Xu
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1089-1115
Open Access | Times Cited: 76
Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial
Sang Min Yoon, So Yeon Kim, Young‐Suk Lim, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 506-515
Open Access | Times Cited: 70
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 593-604
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top